FDA Approves First Interchangeable Biosimilar for Two Rare Diseases ...Middle East

SILVER SPRING, Md., May 28, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which...

Hence then, the article about fda approves first interchangeable biosimilar for two rare diseases was published today ( Wednesday 29/05/2024 - 01:05 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves First Interchangeable Biosimilar for Two Rare Diseases )

Also on site :

• ‘Fire Country’ Announces Major Change After Season 4 Cast Shake-Up
• Roger Waters Calls Sharon Osbourne a ‘Raging Zionist’ in Heated TV Interview
• What's A Knight Of The Seven Kingdoms Like? Allow The New Game Of Thrones Prequel's Cast To Explain